Business Wire

TN-DIGITAL-REASONING

Share
Leading Artificial Intelligence Company, Digital Reasoning, Appoints Brett Jackson as CEO to Accelerate Growth

Brett Jackson has joined Digital Reasoning as the company’s CEO. As a seasoned leader of growth companies in data analytics and enterprise software, Jackson will work with the executive team to drive operational effectiveness, scalability, and new growth opportunities. Founder Tim Estes has transitioned to President after 17 years as the company’s CEO and will be focused on expanding the company’s lead in artificial intelligence that understands human communications for the world’s most important enterprises.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170420005524/en/

“Artificial intelligence is the hottest and most competitive field of technology today. As a company poised for rapid global growth, Digital Reasoning will benefit from having an experienced CEO with a track record of success, including taking a company to IPO, who can navigate the amazing opportunities ahead of us,” said Estes. “We sought a leader who shares our passion for delivering disruptive technology that improves the world. Brett stood out due to his blend of proven leadership and industry knowledge, which will help Digital Reasoning achieve what I set out to accomplish when I founded the company.”

Drawing on the credibility of Digital Reasoning’s trusted technology, Jackson will lead the company through its next business phase by enhancing operations, business development, long-term corporate strategy, as well as driving expansion into new markets. He recently served as CEO and chairman of Logi Analytics, guiding its growth and establishing the company as the leader in embedded analytics. Prior to this, Jackson was CEO of Digital Harbor where he helped the company launch and expand its risk and compliance business in the financial services market. He was also a founding member of Axent Technologies, an enterprise information security company, and was instrumental in taking the company from founding through IPO.

“I was drawn to Digital Reasoning because of its exceptional people and the magnitude of its market opportunity. Tim and his team have created technology that has proven that artificial intelligence can solve some of our most difficult problems and uncover compelling opportunities,” said Jackson. “With this as its foundation, Digital Reasoning has found customers among the world’s leading and most demanding organizations. It is evolving as a global brand and I could not resist the opportunity to combine its long-held mission with new, aggressive business goals for greater impact and reach.”

About Digital Reasoning

Digital Reasoning is a global leader in using artificial intelligence to understand human communications. Our award-winning cognitive computing platform, Synthesys®, automates key tasks and uncovers transformative insights across vast amounts of human communications for many of the world’s most elite companies, organizations, and agencies.

Our technology has been proven to find critical risks and valuable revenue-generating opportunities, delivering rapid and large return on investment in the most complex big data and analytical environments.

Digital Reasoning is headquartered in Nashville, Tennessee, and has offices in Washington, D.C., New York, and London. www.digitalreasoning.com

Contact:

Digital Reasoning
Jason Beck, 615-567-8633
jason.beck@digitalreasoning.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba27.5.2025 17:46:00 CEST | Press release

Galderma Group AG (SWX:GALD): Ad hoc announcement pursuant to Art. 53 LR Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (“ADIA”) and Auba Investment Pte. Ltd. (“Auba”) announced today The repurchased shares will be held in treasury and financed by existing liquidity at hand Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it intends to repurchase approximately 2.4 million Galderma shares in the context of an accelerated bookbuilding offering (“ABO”) of approximately 16.7 million Galderma shares (approximately 7% of Galderma’s share capital) by EQT, ADIA and Auba. Galderma will participate in the ABO at the same price per share which will be determined in the bookbuilding. The repurchased shares will be financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to de

New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration27.5.2025 17:44:00 CEST | Press release

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19. The Minister’s visit highlights a deepening collaboration between South Korea and Australia in the field of clinical research and highlights the strategic importance of cross-border partnerships in advancing global drug development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527294947/en/ Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong,

LambdaTest Introduces Automation MCP Server to Revolutionize Test Failure Triaging27.5.2025 17:00:00 CEST | Press release

~New server connects AI assistants directly to test execution data, streamlining debugging and accelerating development~ LambdaTest, a unified agentic AI and cloud engineering platform, has announced the launch of its Automation MCP Server, a breakthrough solution designed to simplify and accelerate the process of triaging test failures. By enabling direct integration between AI assistants and LambdaTest’s test execution data, the Automation MCP Server empowers developers and QA engineers to investigate and resolve issues faster, without leaving their integrated development environment (IDE). The Automation MCP Server offers a seamless interface within the IDE, allowing users to access and analyze real-time test data with ease. With intelligent root cause analysis, the MCP server can quickly identify the underlying reasons for test failures and take immediate action to fix the underlying code. This results in fewer debugging cycles and faster release times. The server also enhances aut

The Six Winning Projects of the 12th Edition of the IBSA Foundation Fellowships have been Awarded and the 2025 Call is Now Open27.5.2025 16:58:00 CEST | Press release

The winners of the 2024 IBSA Foundation Fellowships Call come from two US, two Swedish, one Italian and one British universities.This year’s edition set a new record: 259 projects submitted from 45 countries.The awards ceremony was held today in Milan; during the event, the 2025 call for applications was officially opened. Research means investing in the future. This is the guiding principle behind the IBSA Foundation Fellowships programme, which for over a decade has supported talented researchers under 40 from universities and research institutions around the world. The programme awards grants to promote innovative and potentially groundbreaking projects in lesser-explored scientific fields; a constantly growing success, also confirmed by the 2024 edition, which marked a new record, with 259 applications across five scientific areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522244202/en/ The Award Ceremony of the

Rigaku Completes New Building at Yamanashi Plant27.5.2025 16:00:00 CEST | Press release

Dramatic 2.7-fold increase in floor space to serve global demand Rigaku Corporation, a global solution partner in X-ray analytical technologies and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; hereinafter “Rigaku”) completed an additional manufacturing building (hereinafter “the New Building”) at Yamanashi Plant, Rigaku’s main production facility. The facility was established to serve as the center of Rigaku’s production framework, in anticipation of global business growth and expansion in product demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527974928/en/ Exterior view of the New Building, Yamanashi Plant Doubling of production capacity: a strategic base to support Rigaku’s growth Demand for X-ray analytical solutions has soared in recent years, both in Japan and worldwide. To respond to growing demand, Rigaku implemented this expansion with two

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye